New stent aims to fix deadly aortic aneurysms without open surgery

NCT ID NCT06385379

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called the WeFlow-Tribranch stent graft system to repair aneurysms or ulcers in the aortic arch. About 90 people aged 18 to 80 with these conditions will receive the stent through a minimally invasive procedure. The main goal is to see if the device is safe and effective by measuring survival and freedom from major stroke within 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC ARCH ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm, Aortic Arch thoracic aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    RECRUITING

    Beijing, China

  • Chinese PLA Gencral Hosptial

    RECRUITING

    Beijing, China

  • First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, China

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    RECRUITING

    Guangzhou, China

  • Nanjing First Hospital

    RECRUITING

    Nanjing, China

  • Shandong Provincial Hospital

    RECRUITING

    Jinan, China

  • Shanghai Chest Hospital

    RECRUITING

    Shanghai, China

  • The Affiliated Hospital Of Qingdao University

    RECRUITING

    Qingdao, China

  • The First Affiliated Hospital ,Sun Yat-sen University

    RECRUITING

    Guangzhou, China

  • The First Affiliated Hospital of China Medical University

    RECRUITING

    Shenyang, China

  • The First Affiliated Hospital of Harbin Medical University

    RECRUITING

    Harbin, China

  • The First Affiliated Hospital of Nanjing Medical University

    RECRUITING

    Nanjing, China

  • The First Affiliated Hospital of PLA Air Force Military Medical University

    RECRUITING

    Xi'an, China

  • The First Hospital of Jilin University

    RECRUITING

    Changchun, China

  • The First People's Hospital of Yunnan Province

    RECRUITING

    Kunming, China

  • The Second Affiliated Hospital Of Nanchang University

    RECRUITING

    Nanchang, China

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, China

  • Xiamen Cardiovascular Hospital

    RECRUITING

    Xiamen, China

  • Xiangya Hospital of Central South University

    RECRUITING

    Changsha, China

  • Zhongshan Hospital, Fudan University

    RECRUITING

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.